The Edmonton Symptom Assessment System: Poor performance as screener for major depression in patients with incurable cancer

Palliative Medicine

Volumn 30, Issue 6, 2016, Pages 587-598

  Brenne, Elisabeth ^a,b   Loge, Jon H ^a,c,d   Lie, Hanne ^c   Hjermstad, Marianne J ^a,d   Fayers, Peter M ^a,e   Kaasa, Stein ^a,b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

depression; depressive disorder; neoplasms; Palliative care; symptom assessment

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION ASSESSMENT; DIAGNOSTIC TEST ACCURACY STUDY; EDMONTON SYMPTOM ASSESSMENT SYSTEM; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PATIENT HEALTH QUESTIONNAIRE 9; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; ADOLESCENT; CLINICAL TRIAL; DEPRESSIVE DISORDER, MAJOR; EVALUATION STUDY; MIDDLE AGED; MULTICENTER STUDY; NEOPLASM; PATIENT; PROCEDURES; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; QUESTIONNAIRE; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; SYMPTOM ASSESSMENT; VALIDATION STUDY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PATIENTS; PSYCHIATRIC STATUS RATING SCALES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES; SYMPTOM ASSESSMENT; YOUNG ADULT;

EID: 84968739574     PISSN: 02692163     EISSN: 1477030X     Source Type: Journal    
DOI: 10.1177/0269216315620082     Document Type: Article

References (75)

1. Teunissen SC, Wesker W, Kruitwagen C, et al. Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage 2007; 34 (1): 94-104.
2. Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 2011; 12 (2): 160-174.
3. Slade T, Andrews G,. Latent structure of depression in a community sample: a taxometric analysis. Psychol Med 2005; 35 (4): 489-497.
4. Solano JP, Gomes B, Higginson IJ,. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage 2006; 31 (1): 58-69.
5. Andrews G, Brugha T, Thase ME, et al. Dimensionality and the category of major depressive episode. Int J Methods Psychiatr Res 2007; 16 (Suppl. 1): S41-S51.
6. Hotopf M, Chidgey J, Addington-Hall J, et al. Depression in advanced disease: a systematic review. Part 1. Prevalence and case finding. Palliat Med 2002; 16 (2): 81-97.
7. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA, American Psychiatric Association, 2013.
8. World Health Organization. The ICD-10 classification of mental and behavioral disorders: diagnostic criteria for research. Geneva: World Health Organization, 1993.
9. Andrade L, Caraveo-Anduaga JJ, Berglund P, et al. The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys. Int J Methods Psychiatr Res 2003; 12 (1): 3-21.
10. Rodin G, Lloyd N, Katz M, et al. The treatment of depression in cancer patients: a systematic review. Support Care Cancer 2007; 15 (2): 123-136.
11. Rayner L, Price A, Hotopf M, et al. The development of evidence-based European guidelines on the management of depression in palliative cancer care. Eur J Cancer 2011; 47 (5): 702-712.
12. Rayner L, Lee W, Price A, et al. The clinical epidemiology of depression in palliative care and the predictive value of somatic symptoms: cross-sectional survey with four-week follow-up. Palliat Med 2011; 25 (3): 229-241.
13. Greenhalgh J, Long AF, Flynn R,. The use of patient reported outcome measures in routine clinical practice: lack of impact or lack of theory? Soc Sci Med 2005; 60 (4): 833-843.
14. National Comprehensive Cancer Network. National Comprehensive Cancer Network clinical practice guidelines in oncology: distress management, 2014, www.nccn.org/professionals/physician-gls/f-guidelines.asp (. accessed 2015).
15. Cleeland CS, Sloan JA,. Assessing the symptoms of cancer using patient-reported outcomes (ASCPRO): searching for standards. J Pain Symptom Manage 2010; 39 (6): 1077-1085.
16. Kaasa S, Radbruch L,. Palliative care research-priorities and the way forward. Eur J Cancer 2008; 44 (8): 1175-1179.
17. Fiscella K, Ransom S, Jean-Pierre P, et al. Patient-reported outcome measures suitable to assessment of patient navigation. Cancer 2011; 117 (15 Suppl.): 3603-3617.
18. Jordhoy MS, Kaasa S, Fayers P, et al. Challenges in palliative care research; recruitment, attrition and compliance: experience from a randomized controlled trial. Palliat Med 1999; 13 (4): 299-310.
19. Mitchell AJ,. Are one or two simple questions sufficient to detect depression in cancer and palliative care? A Bayesian meta-analysis. Br J Cancer 2008; 98 (12): 1934-1943.
20. Vodermaier A, Linden W, Siu C,. Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Cancer Inst 2009; 101 (21): 1464-1488.
21. Bruera E, Kuehn N, Miller MJ, et al. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 1991; 7 (2): 6-9.
22. Wasteson E, Brenne E, Higginson IJ, et al. Depression assessment and classification in palliative cancer patients: a systematic literature review. Palliat Med 2009; 23 (8): 739-753.
23. Chochinov HM, Wilson KG, Enns M, et al. 'Are you depressed?' Screening for depression in the terminally ill. Am J Psychiatry 1997; 154 (5): 674-676.
24. Lloyd-Williams M, Dennis M, Taylor F,. A prospective study to compare three depression screening tools in patients who are terminally ill. Gen Hosp Psychiatry 2004; 26: 384-389.
25. Kawase E, Karasawa K, Shimotsu S, et al. Evaluation of a one-question interview for depression in a radiation oncology department in Japan. Gen Hosp Psychiatry 2006; 28 (4): 321-322.
26. Warmenhoven F, van Rijswijk E, Engels Y, et al. The Beck Depression Inventory (BDI-II) and a single screening question as screening tools for depressive disorder in Dutch advanced cancer patients. Support Care Cancer 2012; 20 (2): 319-324.
27. Taylor L, Lovell N, Ward J, et al. Diagnosis of depression in patients receiving specialist community palliative care: does using a single screening question identify depression otherwise diagnosed by clinical interview? J Palliat Med 2013; 16 (9): 1140-1142.
28. Nekolaichuk C, Watanabe S, Beaumont C,. The Edmonton Symptom Assessment System: a 15-year retrospective review of validation studies (1991-2006). Palliat Med 2008; 22 (2): 111-122.
29. Richardson LA, Jones GW,. A review of the reliability and validity of the Edmonton Symptom Assessment System. Curr Oncol 2009; 16 (1): 55.
30. Cummings G, Biondo PD, Campbell D, et al. Can the global uptake of palliative care innovations be improved? Insights from a bibliometric analysis of the Edmonton Symptom Assessment System. Palliat Med 2011; 25 (1): 71-82.
31. Sigurdardottir KR, Kaasa S, Rosland JH, et al. The European Association for Palliative Care basic dataset to describe a palliative care cancer population: results from an international Delphi process. Palliat Med 2014; 28 (6): 463-473.
32. Zigmond S, Snaith RP,. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361-370.
33. Vignaroli E, Pace EA, Willey J, et al. The Edmonton Symptom Assessment System as a screening tool for depression and anxiety. J Palliat Med 2006; 9 (2): 296-303.
34. Teunissen SC, de Graeff A, Voest EE, et al. Are anxiety and depressed mood related to physical symptom burden? A study in hospitalized advanced cancer patients. Palliat Med 2007; 21 (4): 341-346.
35. Delgado-Guay M, Parsons HA, Li Z, et al. Symptom distress in advanced cancer patients with anxiety and depression in the palliative care setting. Support Care Cancer 2009; 17 (5): 573-579.
36. Noguera A, Centeno C, Carvajal A, et al. Spanish 'fine tuning' of language to describe depression and anxiety. J Palliat Med 2009; 12 (8): 707-712.
37. Ripamonti CI, Bandieri E, Pessi MA, et al. The Edmonton Symptom Assessment System (ESAS) as a screening tool for depression and anxiety in non-advanced patients with solid or haematological malignancies on cure or follow-up. Support Care Cancer 2014; 22 (3): 783-793.
38. De Haes JC, van Knippenberg FC, Neijt JP,. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer 1990; 62 (6): 1034-1038.
39. Philip J, Smith WB, Craft P, et al. Concurrent validity of the modified Edmonton Symptom Assessment System with the Rotterdam Symptom Checklist and the Brief Pain Inventory. Support Care Cancer 1998; 6 (6): 539-541.
40. Carvajal A, Centeno C, Watson R, et al. A comprehensive study of psychometric properties of the Edmonton Symptom Assessment System (ESAS) in Spanish advanced cancer patients. Eur J Cancer 2011; 47 (12): 1863-1872.
41. Spitzer RL, Kroenke K, Williams JB,. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999; 282 (18): 1737-1744.
42. Bagha SM, Macedo A, Jacks LM, et al. The utility of the Edmonton Symptom Assessment System in screening for anxiety and depression. Eur J Cancer Care 2013; 22: 60-69.
43. Jimenez A, Madero R, Alonso A, et al. Symptom clusters in advanced cancer. J Pain Symptom Manage 2011; 42 (1): 24-31.
44. Kirkova J, Aktas A, Walsh D, et al. Cancer symptom clusters: clinical and research methodology. J Palliat Med 2011; 14 (10): 1149-1166.
45. Brenne E, Loge JH, Kaasa S, et al. Depressed patients with incurable cancer: which depressive symptoms do they experience? Palliat Support Care 2013; 11 (6): 491-501.
46. Hjermstad MJ, Lie HC, Caraceni A, et al. Computer-based symptom assessment is feasible in patients with advanced cancer: results from an international multicenter study, the EPCRC-CSA. J Pain Symptom Manage 2012; 44 (5): 639-654.
47. Knudsen AK, Brunelli C, Kaasa S, et al. Which variables are associated with pain intensity and treatment response in advanced cancer patients?-implications for a future classification system for cancer pain. Eur J Pain 2011; 15 (3): 320-327.
48. Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011; 12 (5): 489-495.
49. Solheim TS, Blum D, Fayers PM, et al. Weight loss, appetite loss and food intake in cancer patients with cancer cachexia: three peas in a pod?-analysis from a multicenter cross sectional study. Acta Oncol 2014; 53 (4): 539-546.
50. Capital Health. Edmonton Symptom Assessment Scale (ESAS)., 2001, http://www.npcrc.org/files/news/edmonton-symptom-assessment-scale.pdf (. accessed 2008).
51. Pfizer. Patient Health Questionnaire (PHQ) Screeners., 2008, http://www.phqscreeners.com/
52. Bland JM, Altman DG,. Survival probabilities (the Kaplan-Meier method). BMJ 1998; 317 (7172): 1572.
53. Löwe B, Spitzer RL, Grafe K, et al. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses. J Affect Disord 2004; 78 (2): 131-140.
54. Swets JA,. Measuring the accuracy of diagnostic systems. Science 1988; 240 (4857): 1285-1293.
55. Fischer JE, Bachmann LM, Jaeschke R,. A readers' guide to the interpretation of diagnostic test properties: clinical example of sepsis. Intensive Care Med 2003; 29 (7): 1043-1051.
56. Cohen J,. Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull 1968; 70 (4): 213-220.
57. Landis JR, Koch GG,. The measurement of observer agreement for categorical data. Biometrics 1977; 33 (1): 159-174.
58. Watanabe S, Nekolaichuk C, Beaumont C, et al. The Edmonton symptom assessment system-what do patients think? Support Care Cancer 2009; 17 (6): 675-683.
59. Bergh I, Kvalem IL, Aass N, et al. What does the answer mean? A qualitative study of how palliative cancer patients interpret and respond to the Edmonton Symptom Assessment System. Palliat Med 2011; 25: 716-724.
60. Lasalvia A, Van Weeghel J, Reneses B, et al. Discrimination reported by people with major depressive disorder-authors' reply. Lancet 2013; 381 (9873): 1181-1182.
61. Selby D, Chakraborty A, Myers J, et al. High scores on the Edmonton Symptom Assessment Scale identify patients with self-defined high symptom burden. J Palliat Med 2011; 14 (12): 1309-1316.
62. Holland JC, Bultz BD, National comprehensive Cancer Network. The NCCN guideline for distress management: a case for making distress the sixth vital sign. J Natl Compr Canc Netw 2007; 5 (1): 3-7.
63. Payne A, Barry S, Creedon B, et al. Sensitivity and specificity of a two-question screening tool for depression in a specialist palliative care unit. Palliat Med 2007; 21 (3): 193-198.
64. Watanabe SM, Nekolaichuk CL, Beaumont C,. The Edmonton Symptom Assessment System, a proposed tool for distress screening in cancer patients: development and refinement. Psychooncology 2012; 21 (9): 977-985.
65. Pirl WF, Greer JA, Traeger L, et al. Depression and survival in metastatic non-small-cell lung cancer: effects of early palliative care. J Clin Oncol 2012; 30 (12): 1310-1315.
66. Baker-Glenn EA, Park B, Granger L, et al. Desire for psychological support in cancer patients with depression or distress: validation of a simple help question. Psychooncology 2011; 20 (5): 525-531.
67. Kroenke K, Spitzer RL, Williams JB,. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16 (9): 606-613.
68. Diez-Quevedo C, Rangil T, Sanchez-Planell L, et al. Validation and utility of the patient health questionnaire in diagnosing mental disorders in 1003 general hospital Spanish inpatients. Psychosom Med 2001; 63 (4): 679-686.
69. Williams LS, Brizendine EJ, Plue L, et al. Performance of the PHQ-9 as a screening tool for depression after stroke. Stroke 2005; 36 (3): 635-638.
70. Carballeira Y, Dumont P, Borgacci S, et al. Criterion validity of the French version of Patient Health Questionnaire (PHQ) in a hospital department of internal medicine. Psychol Psychother 2007; 80 (Pt 1): 69-77.
71. Thekkumpurath P, Walker J, Butcher I, et al. Screening for major depression in cancer outpatients: the diagnostic accuracy of the 9-item patient health questionnaire. Cancer 2011; 117 (1): 218-227.
72. Wittkampf KA, Naeije L, Schene AH, et al. Diagnostic accuracy of the mood module of the Patient Health Questionnaire: a systematic review. Gen Hosp Psychiatry 2007; 29 (5): 388-395.
73. Luckett T, Butow PN, King MT, et al. A review and recommendations for optimal outcome measures of anxiety, depression and general distress in studies evaluating psychosocial interventions for English-speaking adults with heterogeneous cancer diagnoses. Support Care Cancer 2010; 18 (10): 1241-1262.
74. Kathol RG, Mutgi A, Williams J, et al. Diagnosis of major depression in cancer patients according to four sets of criteria. Am J Psychiatry 1990; 147 (8): 1021-1024.
75. Lie HC, Hjermstad MJ, Fayers P, et al. Depression in advanced cancer-assessment challenges and associations with disease load. J Affect Disord 2015; 173: 176-184.